An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor

Gynecologic Oncology - Tập 153 - Trang 541-548 - 2019
Martin Gore1, Allan Hackshaw2, William E. Brady3, Richard T. Penson4, Richard Zaino5, W. Glenn McCluggage6, Raji Ganesan7, Nafisa Wilkinson8, Timothy Perren9, Ana Montes10, Jeffrey Summers11, Rosemary Lord12, Graham Dark13, Gordon Rustin14, Melanie Mackean15, Nicholas Reed16, Sean Kehoe17, Michael Frumovitz18, Helen Christensen2, Amanda Feeney2
1Royal Marsden NHS Foundation Trust, London, UK
2Cancer Research UK & UCL Cancer Trials Centre, London, UK
3Roswell Park Comprehensive Cancer Centre, Buffalo, USA
4Massachusetts General Hospital, Boston, USA
5Penn State Health Milton S. Hershey Medical Centre, PA, USA
6Dept of Pathology, Belfast Health & Social Care Trust, Belfast, UK
7Birmingham Women’s Hospital, Birmingham, UK
8University College London Hospitals NHS Foundation Trust, London, UK
9Leeds Teaching Hospitals NHS Trust, Leeds, UK
10Guy’s and St Thomas’ NHS Foundation Trust, London, UK
11Maidstone and Tunbridge Wells NHS Foundation Trust, Kent, UK
12Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK
13Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
14Mount Vernon Cancer Centre, Middlesex, UK
15Edinburgh Cancer Centre, Edinburgh, UK
16Beatson Oncology Centre, Glasgow, UK
17Institute of Cancer and Genomics, University of Birmingham, Birmingham, UK
18The University of Texas MD Anderson Cancer Centre, Houston, TX, USA

Tài liệu tham khảo